Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.

Saved in:
Bibliographic Details
Title: Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.
Authors: Roozendaal R; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands. RRoozend@its.jnj.com., Hendriks J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., van Effelterre T; Janssen R&D, Beerse, Belgium., Spiessens B; Janssen R&D, Beerse, Belgium., Dekking L; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Solforosi L; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Czapska-Casey D; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Bockstal V; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Stoop J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Splinter D; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.; argenx BV, Gent, Belgium., Janssen S; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Baelen BV; Janssen R&D, Beerse, Belgium.; BVB Clin Consult BVBA, Mechelen, Belgium., Verbruggen N; Janssen R&D, Beerse, Belgium.; Galapagos NV, Mechelen, Belgium., Serroyen J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Dekeyster E; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Volkmann A; Bavarian Nordic, Munich, Germany., Wollmann Y; Bavarian Nordic, Munich, Germany.; FGK Clinical Research, Munich, Germany., Carrion R Jr; Texas Biomedical Research Institute, San Antonio, TX, USA., Giavedoni LD; Texas Biomedical Research Institute, San Antonio, TX, USA., Robinson C; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Leyssen M; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Douoguih M; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Luhn K; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Pau MG; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Sadoff J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Vandebosch A; Janssen R&D, Beerse, Belgium., Schuitemaker H; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Zahn R; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands., Callendret B; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
Source: NPJ vaccines [NPJ Vaccines] 2020 Dec 17; Vol. 5 (1), pp. 112. Date of Electronic Publication: 2020 Dec 17.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-0105
DOI:10.1038/s41541-020-00261-9